You are here

P&T News

December 18

Drug Expected to Launch in 2019, Offering Hope to 35 Million U.S. Adults
New Antifungal Has Increased Bioavailability and Reduced Variability

December 11

BTC Is a Group of Rare Gastrointestinal Cancers With Limited Treatment Options, Poor Outcomes
Study Demonstrates Rapid Response in Patients, and Doesn’t Affect Tamoxifen Efficacy
Prescription App Can Serve As Training, Monitoring, and Reminder Tool

December 4

Resorbable Dextenza is the First Intracanalicular Insert for Drug Delivery
Patients with MS Suffered Stroke, Blood Vessel Tearing in Head and Neck After Receiving Drug
First Biosimilar For Adults With CD20-Positive, B-Cell Non-Hodgkin’s Lymphoma
Life-Threatening Side Effect of Drug for Acute Myeloid Leukemia
First Drug for Rare Autoimmune Disorder That Affects Nerve, Muscles Connection
Hope For Patients With Highly Aggressive Form of AML

November 27

Oncology Therapy for Adult and Pediatric Tumors With a Neurotrophic Receptor Tyrosine Kinase (NTRK) Gene Fusion
First Hedgehog Pathway Inhibitor Approved for AML in Adults Aged 75 and Older
Gene Therapy Granted Regenerative Medicine, Fast Track Designations
More Than 80,000 Injuries Have Been Associated With Medical Devices for Pain Management Since 2008

November 20

First and Only Treatment for Rare Hyper-Inflammation Syndrome With High Mortality
First-Line Treatment for People With Life-Threatening Blood Disorder
Use of Non-Approved Pain Medications Could Cause Dosing Errors, Pump Failures

Pages